IgG4-related disease: what do we know after 20 years

Cover Page


IgG4-related disease is immunomediated fibroinflammatory condition, characterized by tumefective lesions in different organs with distinctive pathomorphological features and IgG4 hypersecretion in serum and tissues in the majority of patients. IgG4-RD has been established as a separate clinical in the early 2000s. In the review we focus on the evolution of views on ethiopathogenesis of the disease, therapeutic and diagnostic options and classification of the disease.

Full Text

Restricted Access

About the authors

E. V. Sokol

Nasonova Research Institute of Rheumatology

Author for correspondence.
Email: name.sokol@gmail.com
ORCID iD: 0000-0002-2191-9361

Russian Federation, Moscow

к.м.н., науч. сотр. лаб. интенсивных методов терапии ревматических заболеваний


  1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012 Feb 9;366(6):539-51. doi: 10.1056/NEJMra1104650
  2. Wallace ZS, Perugino C, Matza M, et al. Immunoglobulin G4–related Disease. Clin Chest Med. 2019;583-97. doi: 10.1016/j.ccm.2019.05.005
  3. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001 Mar 8;344(10):732-8.
  4. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593
  5. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012 Sep;25(9):1181-92. doi: 10.1038/modpathol.2012.72
  6. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012 Feb;22(1):21-30. doi: 10.1007/s10165-011-0571-z
  7. Wallace ZS, Zhang Y, Perugino CA, et al; ACR/EULAR IgG4-RD Classification Criteria Committee. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 Mar;78(3):406-12. doi: 10.1136/annrheumdis-2018-214603
  8. Masamune A, Kikuta K, Hamada S, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2016. J Gastroenterol. 2019 Dec 23. doi: 10.1007/s00535-019-01658-7
  9. Сокол Е.В., Васильев В.И., Пальшина С.Г. и др. Клинико-лабораторная характеристика IgG4-связанного заболевания и алгоритм его диагностики. Терапевтический архив. 2019;91(5):40-8 [Sokol EV, Vasilyev VI, Palshina SG, et al. Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm. Therapeutic Archive. 2019;91(5):40-8 (In Russ.)]. doi: 10.26442/00403660.2019.05.000236
  10. Wang L, Zhang P, Wang M, et al. Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2
  11. Pillai S, Perugino C, Kaneko N. Immune mechanisms of fibrosis and inflammation in IgG4-related disease. Curr Opin Rheumatol. 2019 Dec 13. doi: 10.1097/BOR.0000000000000686
  12. de Buy Wenniger LJ1, Culver EL, Beuers U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology. 2014 Oct;60(4):1453-4. doi: 10.1002/hep.26999
  13. Седышев C.Х., Васильев В.И., Ковригина А.М., Насонов Е.Л. IgG4-связанное системное заболевание. Современный взгляд на «старые» болезни. Научно-практическая ревматология. 2012;54(5):64-72 [Sedyshev SH, Vasilyev VI, Kovrigina AM, Nasonov EL. IgG4-related systemic disease. Contemporary view on «old» diseases. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2012;54(5):64-72 (In Russ.)].
  14. Geyer JT, Ferry JA, Harris NL, et al. Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol. 2010 Feb;34(2):202-10. doi: 10.1097/PAS.0b013e3181c811ad
  15. Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria. J Gastroenterol. 2007 May;42(Suppl.)18:39-41. doi: 10.1007/s00535-007-2046-8
  16. Kanno A, Masamune A, Okazaki K, et al; Research Committee of Intractable Diseases of the Pancreas. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas. 2015 May;44(4):535-9. doi: 10.1097/MPA.0000000000000325
  17. Shimosegawa T, Chari ST, Frulloni L, et al; International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas. 2011 Apr;40(3):352-8. doi: 10.1097/MPA.0b013e3182142fd2
  18. Carruthers MN, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis. 2015 Jan;74(1):14-8. doi: 10.1136/annrheumdis-2013-204907
  19. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011 Mar;64(3):237-43. doi: 10.1136/jcp.2010.085613
  20. Сокол Е.В., Черкасова М.В., Торгашина А.В. Диагностическая ценность IgG4 сыворотки крови при IgG4-связанном заболевании: так ли она велика? Современная ревматология. 2019;13(1):52-7 [Sokol EV, Cherkasova MV, Torgashina AV. The diagnostic value of serum IgG4 for the diagnosis of IgG4-related disease: andis that so great? Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2019;13(1):52-7 (In Russ.)]. doi: 10.14412/1996-7012-2019-1-52-57
  21. Khosroshahi, A. Cheryk LA, Carruthers MN, et al. Brief Report: spuriously low serum IgG4 concentrations caused by the prozone phenomenon in patients with IgG4-related disease. Arthritis Rheumatol. 2014 Jan;66(1):213-7. doi: 10.1002/art.38193
  22. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan;74(1):190-5. doi: 10.1136/annrheumdis-2014-205233
  23. Wallace ZS, Naden RP, Chari S, et al; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561
  24. Koizumi S, Kamisawa T, Kuruma S, et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases? World J Gastroenterol. 2013 Sep 21;19(35):5769-74. doi: 10.3748/wjg.v19.i35.5769
  25. Sasaki T, Yajima T, Shimaoka T, et al. Synergistic effect of IgG4 antibody and CTLs causes tissue inflammation in IgG4-related disease. Int Immunol. 2019 Nov 12. pii: dxz073. doi: 10.1093/intimm/dxz073
  26. Mattoo H, Stone JH, Pillai S. Clonally expanded cytotoxic CD4+ T cells and the pathogenesis of IgG4-related disease. Autoimmunity. 2017 Feb;50(1):19-24. doi: 10.1080/08916934
  27. Shiokawa M, Kodama Y, Kuriyama K, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut. 2016 Aug;65(8):1322-32. doi: 10.1136/gutjnl-2015-310336
  28. Perugino CA, Mattoo H, Mahajan VS, et al. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol. 2017 Sep;69(9):1722-32. doi: 10.1002/art.40168
  29. Pillai S. T and B lymphocytes in fibrosis and systemic sclerosis. Curr Opin Rheumatol. 2019 Nov;31(6):576-81. doi: 10.1097/BOR.0000000000000644
  30. Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep;134(3):679-87. doi: 10.1016/j.jaci.2014.03.034
  31. Miyabe K, Zen Y, Cornell LD, et al. Gastrointestinal and Extra-Intestinal Manifestations of IgG4–Related Disease. Gastroenterology. 2018 Oct;155(4):990-1003.e1. doi: 10.1053/j.gastro.2018.06.082
  32. Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015 Apr;94(15):e680. doi: 10.1097/MD.0000000000000680
  33. Васильев В.И., Сафонова Т.Н., Сокол Е.В. и др. Диагностика IgG4-связанного офтальмологического заболевания в группе больных с различными поражениями глаз и области орбит. Терапевтический архив. 2018;90(5):61-71 [Vasilyev VI, Safonova TN, Socol EV, et al. Diagnosis of IgG4-related ophthalmic disease in a group of patients with various lesions of the eye and orbits. Therapeutic Archive. 2018;90(5):61-71 (In Russ.)]. doi: 10.26442/terarkh2018905671-71
  34. Васильев В.И., Сокол Е.В., Родионова Е.Б. и др. Связанные с IgG-4 поражения слюнных желез. Терапевтический архив. 2015;87(8):92-102 [Vasilyev VI, Sokol EV, Rodionova EB, et al. IgG4-related salivary gland lesions. Therapeutic Archive. 2015;87(8):92-102 (In Russ.)]. doi: 10.17116/terarkh201587892-102
  35. Della-Torre E, Mattoo H, Mahajan VS, et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy. 2014 Feb;69(2):269-72. doi: 10.1111/all.12320
  36. Hong X, Sun ZP, Li W, Chen Y, Gao Y, Su JZ et al. Comorbid diseases of IgG4-related sialadenitis in the head and neck region. Laryngoscope. 2015 Sep;125(9):2113-8. doi: 10.1002/lary.25387.
  37. Сокол Е.В., Васильев В.И., Ковригина А.М. и др. Связанное с IgG4 заболевание и В-клеточная клональная лимфоидная полиферация: описание двух клинических случаев и обзор литературы. Терапевтический архив. 2015;87(12):77-84 [Sokol EV, Vasilyev VI, Kovrigina AM, et al. IgG4-related disease and clonal B-cell lymphoid proliferation: description of two clinical cases and review of literature. Therapeutic Archive. 2015;87(12):77-84 (In Russ.)]. doi: 10.17116/ terarkh2015871277-84oi:10.17116/terarkh2015871277-84
  38. Казанцева И.А., Лищук С.В., Грибунов Ю.П. и др. Сочетание рака желудка с IgG4-связанной болезнью (клиническое наблюдение и обзор литературы). Архив патологии. 2016;78(4):43-7 [Kazantse- va IA, Lishchuk SV, Gribiv YuP, et al. Gastric cancer concurrent with IgG4-related disease: A clinical case and a review of literature. Archive patologii. 2016;78(4):43-7 (In Russ.)]. doi: 10.17116/ patol201678443-47
  39. Wallace ZS, Wallace CJ, Lu N, et al. Stone JH. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 Sep;68(9):2283-9. doi: 10.1002/art.39773
  40. Sato Y, Ohshima K, Takata K, et al. Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease. J Clin Exp Hematop. 2012;52(1):51-5.
  41. Cheuk W, Yuen HK, Chan AC, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacry-oadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008 Aug;32(8):1159-67. doi: 10.1097/PAS.0b013e31816148ad
  42. Yamamoto M, Takahashi H, Tabeya T, et al. Risk of malignancies in IgG4-related disease. Mod Rheumatol. 2012 Jun;22(3):414-8. doi: 10.1007/s10165-011-0520-x
  43. Shiokawa M, Kodama Y, Yoshimura K, et al. Risk of cancer in patients with autoimmune pancreatitis. Am J Gastroenterol. 2013 Apr;108(4):610-7. doi: 10.1038/ajg.2012.465
  44. Hart PA, Law RJ, Dierkhising RA, et al. Risk of cancer in autoimmune pancreatitis: a case-control study and review of the literature. Pancreas. 2014 Apr;43(3):417-21. doi: 10.1097/MPA.0000000000000053
  45. Hirano K, Tada M, Sasahira N, et al. Incidence of malignancies in patients with IgG4-related disease. Intern Med. 2014;53(3):171-6.
  46. Carruthers MN, Topazian MD, Khosroshahi A, et al.. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605
  47. Khosroshahi A, Wallace ZS, Crowe JL, et al. Second International Symposium on IgG4-Related Disease International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132
  48. Сокол Е.В., Васильев В.И. Лечение IgG4-связанного заболевания. Научно-практическая ревматология. 2016; 54(3): 352-60 [Sokol EV, Vasilyev VI. Treatment of IgG4-related disease. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2016; 54(3):352-60 (In Russ.)]. doi: 10.14412/1995-4484-2016-352-360



Abstract - 51

PDF (Russian) - 32





  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies